Bergemann N - Search Results

1

Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients.

Bergemann N, Frick A, Parzer P, Kopitz J. Bergemann N, et al. Pharmacopsychiatry. 2004 Mar;37(2):63-8. doi: 10.1055/s-2004-815527. Pharmacopsychiatry. 2004. PMID: 15048613 Clinical Trial.

2

Asymptomatic pancreatitis associated with clozapine.

Bergemann N, Ehrig C, Diebold K, Mundt C, von Einsiedel R. Bergemann N, et al. Pharmacopsychiatry. 1999 Mar;32(2):78-80. doi: 10.1055/s-2007-979197. Pharmacopsychiatry. 1999. PMID: 10333168 Review.

3

H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures.

von Einsiedel RW, Roesch-Ely D, Diebold K, Sartor K, Mundt C, Bergemann N. von Einsiedel RW, et al. Among authors: bergemann n. Pharmacopsychiatry. 2002 Jul;35(4):152-4. doi: 10.1055/s-2002-33193. Pharmacopsychiatry. 2002. PMID: 12163986

4

Acute psychiatric admission and menstrual cycle phase in women with schizophrenia.

Bergemann N, Parzer P, Nagl I, Salbach B, Runnebaum B, Mundt Ch, Resch F. Bergemann N, et al. Arch Womens Ment Health. 2002 Nov;5(3):119-26. doi: 10.1007/s00737-002-0004-2. Arch Womens Ment Health. 2002. PMID: 12510215

5

Omeprazole reduces clozapine plasma concentrations. A case report.

Frick A, Kopitz J, Bergemann N. Frick A, et al. Among authors: bergemann n. Pharmacopsychiatry. 2003 May;36(3):121-3. doi: 10.1055/s-2003-39980. Pharmacopsychiatry. 2003. PMID: 12806570

6

Plasma amisulpride levels in schizophrenia or schizoaffective disorder.

Bergemann N, Kopitz J, Kress KR, Frick A. Bergemann N, et al. Eur Neuropsychopharmacol. 2004 May;14(3):245-50. doi: 10.1016/j.euroneuro.2003.09.001. Eur Neuropsychopharmacol. 2004. PMID: 15056484 Clinical Trial.

7

Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics.

Bergemann N, Mundt C, Parzer P, Jannakos I, Nagl I, Salbach B, Klinga K, Runnebaum B, Resch F. Bergemann N, et al. Schizophr Res. 2005 Mar 1;73(2-3):357-66. doi: 10.1016/j.schres.2004.06.013. Schizophr Res. 2005. PMID: 15653282

8

Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study.

Bergemann N, Mundt C, Parzer P, Pakrasi M, Eckstein-Mannsperger U, Haisch S, Salbach B, Klinga K, Runnebaum B, Resch F. Bergemann N, et al. Schizophr Res. 2005 May 1;74(2-3):125-34. doi: 10.1016/j.schres.2004.12.009. Schizophr Res. 2005. PMID: 15721993 Clinical Trial.

9

Amisulpride has no effect on plasma clozapine concentrations.

Bergemann N, Kress KR, Frick A, Kopitz J. Bergemann N, et al. J Clin Psychopharmacol. 2005 Oct;25(5):494-7. doi: 10.1097/01.jcp.0000178418.68050.0d. J Clin Psychopharmacol. 2005. PMID: 16160629 Clinical Trial. No abstract available.

10

Valproate lowers plasma concentration of olanzapine.

Bergemann N, Kress KR, Abu-Tair F, Frick A, Kopitz J. Bergemann N, et al. J Clin Psychopharmacol. 2006 Aug;26(4):432-4. doi: 10.1097/01.jcp.0000227353.46450.52. J Clin Psychopharmacol. 2006. PMID: 16855466 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters